Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: TIAPRIDE |
ATC code: N05A L03 |
Document link:
Tiapride STUDY 73-00079-EN-00.xls
|
Document date: 2013-03-15
|
Study number: 73-00079-EN-00 |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|